We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-8.62%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$902M
AUM Growth
-$613M
Cap. Flow
-$411M
Cap. Flow %
-45.55%
Top 10 Hldgs %
57.67%
Holding
342
New
42
Increased
40
Reduced
54
Closed
115

Top Buys

Rank Stock Value
1
AMRX icon
Amneal Pharmaceuticals
AMRX
+$6.87M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$3.2M
3
TSM icon
TSMC
TSM
+$1.88M
4
BKNG icon
Booking.com
BKNG
+$1.49M
5
WPM icon
Wheaton Precious Metals
WPM
+$1.48M

Top Sells

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$33.8M
2
ARRY
Array Biopharma Inc
ARRY
+$23.1M
3
INCY icon
Incyte
INCY
+$10.1M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$9.75M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$9.33M

Sector Composition

Rank Sector Weight
1 Healthcare 16.66%
2 Industrials 5.91%
3 Financials 5.49%
4 Technology 5.04%
5 Communication Services 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZEPP
276
Zepp Health
ZEPP
$64.8M
– –
-6,459
Closed -$258K
PVLA
277
Palvella Therapeutics
PVLA
$2.15B
– –
-4,559
Closed -$1.62M
VBIV
278
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-35,038
Closed -$1.16M
MRNS
279
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-71,215
Closed -$1.12M
EIGR
280
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-4,840
Closed -$1.55M
FRTX
281
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
– –
-994
Closed -$265K
SGEN
282
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-132,605
Closed -$8.92M
ACER
283
DELISTED
Acer Therapeutics Inc
ACER
– –
-15,700
Closed -$54K
PRTK
284
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-227,383
Closed -$875K
INFI
285
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-418,296
Closed -$728K
MTEM
286
DELISTED
Molecular Templates, Inc.
MTEM
– –
-9,614
Closed -$1.13M
SPPI
287
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-95,246
Closed -$830K
AGRX
288
DELISTED
Agile Therapeutics
AGRX
– –
-206
Closed -$580K
OBSV
289
DELISTED
ObsEva SA Ordinary Shares
OBSV
– –
-194,991
Closed -$2.11M
FSTX
290
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-7,775
Closed -$122K
ALBO
291
DELISTED
Albireo Pharma Inc
ALBO
– –
-197,005
Closed -$6.26M
QTNT
292
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-6,849
Closed -$2.59M
CCXI
293
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-128,637
Closed -$1.15M
ALNA
294
DELISTED
Allena Pharmaceuticals
ALNA
– –
-29,877
Closed -$124K
ATRS
295
DELISTED
Antares Pharma, Inc.
ATRS
– –
-809,378
Closed -$2.57M
DRNA
296
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-188,673
Closed -$2.97M
ADMS
297
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-223,959
Closed -$1.33M
KDMN
298
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-161,877
Closed -$317K
TBIO
299
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
-60,683
Closed -$780K
CHMA
300
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-123,954
Closed -$923K
9 10 11
12
13

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Fosun International's Q3 2019 Portfolio in Review

As of Q3 2019, Fosun International held 342 positions worth $902M, down 40% from $1.51B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Fosun International withdrew a net $411M in Q3 2019, closing 115 positions and reducing 54 holdings. Its most notable exit was DigitalBridge, an estimated $33.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 32% a quarter earlier, followed by Industrials and Financials.

Against the trend, Fosun International opened a new position in Zoetis worth $1.24M.

  • Fosun International's largest Q3 2019 buy was Zoetis: 10,000 shares worth $1.24M.
  • Fosun International added most to Amneal Pharmaceuticals in Q3 2019, an estimated $6.87M increase.
  • Fosun International's biggest Q3 2019 reduction was BioMarin Pharmaceuticals, cutting an estimated $7.14M.
  • Fosun International fully exited DigitalBridge in Q3 2019, selling an estimated $33.8M.
  • Fosun International's ten largest holdings make up 58% of its $902M portfolio in Q3 2019.
  • Fosun International opened 42 new positions and closed 115 in Q3 2019.
  • Fosun International's portfolio value fell 40% quarter-over-quarter to $902M.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.